N-acetylglucomsamine

starfish · 06-21-2008, 07:01 AM

I tried to search to see if this was discussed in the past but I think it was too long of a word.

http://www.msrc.co.uk/index.cfm?fuse...ow&pageid=1861

This is not the same thing they use for inflammation of the joints. It is slightly different. Anyone know anything more about this or try taking it?

It does not cite specific levels to take for therapy purposes.

Bearygood · 06-21-2008, 10:31 AM

Hi, starfish, yes. I haven't seen any updates from USC but here are two articles about it from last year:

http://today.uci.edu/news/release_detail.asp?key=1612

http://today.uci.edu/news/release_detail.asp?key=1666

jackD · 06-21-2008, 12:14 PM

This might only apply to a subset of MS folks who have a specific "inherited trait/defect".

I take the stuff on pure blind faith(hope) that it will do some good.

I get mine from the Vitamin Shoppe.

http://www.vitaminshoppe.com/store/e...jsp?id=SR-5476

Here is the results of a product search I did..

http://www.shopping.com/xPC-Source_N...mg_120_Tablets

jackD

p.s. The label says N.A.G. - this is the short name.

Quote:

1: J Biol Chem. 2007 Nov 16;282(46):33725-34. Epub 2007 Sep 13. Links
N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration.

Lee SU, Grigorian A, Pawling J, Chen IJ, Gao G, Mozaffar T, McKerlie C, Demetriou M.
Department of Neurology, University of California, Irvine, California 92697, USA.

Multiple sclerosis (MS) is characterized by inflammatory demyelination of axons and neurodegeneration, the latter inadequately modeled in experimental autoimmune encephalomyelitis (EAE).

Susceptibility of inbred mouse strains to EAE is in part determined by major histocompatibility complex haplotype; however, other molecular mechanisms remain elusive. Galectins bind GlcNAc-branched N-glycans attached to surface glycoproteins, forming a molecular lattice that restricts lateral movement and endocytosis of glycoproteins. GlcNAc branching negatively regulates T cell activity and autoimmunity, and when absent in neurons, induces apoptosis in vivo in young adult mice. We find that EAE susceptible mouse strains PL/J, SJL, and NOD have reduced GlcNAc branching. PL/J mice display the lowest levels, partial deficiencies in N-acetylglucosaminyltransferase I, II, and V (i.e. Mgat1, -2, and -5), T cell hyperactivity and spontaneous late onset inflammatory demyelination and neurodegeneration; phenotypes markedly enhanced by Mgat5(+/-) and Mgat5(-/-) backgrounds in a gene dose-dependent manner. Spontaneous disease is transferable and characterized by progressive paralysis, tremor, dystonia, neuronophagia, and axonal damage in both demyelinated lesions and normal white matter, phenocopying progressive MS.

Our data identify hypomorphic Golgi processing as an inherited trait that determines susceptibility to EAE, provides a unique spontaneous model of MS, and suggests GlcNAc-branching deficiency may promote T cell-mediated demyelination and neurodegeneration in MS.

PMID: 17855338 [PubMed - indexed for MEDLINE]

starfish · 06-21-2008, 03:59 PM

Thank you Bearygood for those sites. I would like to see more studies repeat these results.

I have a little arthritis, and it sounds like it is effective for that, too, so no matter what, it sounds like a good thing to take.

Thank you JackD for the research article and the resources to buy it online. I will check my local sources and comparison shop.

Site Navigation

NeuroTalk Online Support Groups

N-acetylglucomsamine

NeuroTalk Forums